Jack Lin
Stock Analyst at Morgan Stanley
(1.10)
# 3,846
Out of 5,060 analysts
29
Total ratings
47.6%
Success rate
-2.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Lin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2256 Abbisko Cayman Limited | Reiterated: Buy | $22.00 | $7.75 | +183.87% | 2 | Sep 4, 2026 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $215.00 → $212.00 | $91.30 | +132.20% | 4 | Aug 26, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $123.00 → $138.50 | $89.05 | +55.53% | 2 | Aug 25, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Reiterated: Buy | $17.00 | $12.32 | +37.99% | 4 | Aug 25, 2026 | |
| HCM HUTCHMED (China) | Upgraded: Hold | $14 → $14 | $14.16 | -3.92% | 3 | May 28, 2026 | |
| HKG: 0013 HUTCHMED (China) Limited | Reiterated: Hold | $21.45 → $21.30 | $22.28 | -4.40% | 3 | May 28, 2026 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Reiterated: Buy | $493.00 | $170.00 | +190.00% | 2 | Nov 20, 2025 | |
| HKG: 9688 Zai Lab Limited | Reiterated: Buy | $37.50 → $37.44 | $18.60 | +101.29% | 2 | Nov 6, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Hold | $89.00 | $65.90 | +35.05% | 2 | Oct 30, 2025 | |
| HKG: 1952 Everest Medicines Limited | Reiterated: Hold | $55.00 | $32.36 | n/a | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93.50 | $81.95 | n/a | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $23.16 | n/a | 3 | Sep 21, 2025 |
Abbisko Cayman Limited
Sep 4, 2026
Reiterated: Buy
Price Target: $22.00
Current: $7.75
Upside: +183.87%
Akeso, Inc.
Aug 26, 2026
Reiterated: Buy
Price Target: $215.00 → $212.00
Current: $91.30
Upside: +132.20%
Innovent Biologics, Inc.
Aug 25, 2026
Reiterated: Buy
Price Target: $123.00 → $138.50
Current: $89.05
Upside: +55.53%
InnoCare Pharma Limited
Aug 25, 2026
Reiterated: Buy
Price Target: $17.00
Current: $12.32
Upside: +37.99%
HUTCHMED (China)
May 28, 2026
Upgraded: Hold
Price Target: $14 → $14
Current: $14.16
Upside: -3.92%
HUTCHMED (China) Limited
May 28, 2026
Reiterated: Hold
Price Target: $21.45 → $21.30
Current: $22.28
Upside: -4.40%
Duality Biotherapeutics, Inc.
Nov 20, 2025
Reiterated: Buy
Price Target: $493.00
Current: $170.00
Upside: +190.00%
Zai Lab Limited
Nov 6, 2025
Reiterated: Buy
Price Target: $37.50 → $37.44
Current: $18.60
Upside: +101.29%
RemeGen Co., Ltd.
Oct 30, 2025
Reiterated: Hold
Price Target: $89.00
Current: $65.90
Upside: +35.05%
Everest Medicines Limited
Sep 22, 2025
Reiterated: Hold
Price Target: $55.00
Current: $32.36
Upside: n/a
Sep 22, 2025
Reiterated: Buy
Price Target: $93.50
Current: $81.95
Upside: n/a
Sep 21, 2025
Reiterated: Buy
Price Target: $50 → $48
Current: $23.16
Upside: n/a